United Kingdom · Founded 2015 · Privately Held (backing)
Developer of advanced cancer treatment intended for targeting hard-to-treat cancers. Pheon Therapeutics is based in United Kingdom and was founded in 2015. Its last known valuation is $173 million. It has raised $191 million.
Last price · $/share
—
Implied valuation
$172.7M
Total raised
$191.1M
Last round
—
Team — not yet on record
No current team members for Pheon Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Pheon Therapeutics with a free account
·The complete investor list: 11 names
·Watch Pheon Therapeutics: the Monday email on marks, rounds and moves
